These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34884224)

  • 1. Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia.
    Imamura T; Oshima A; Narang N; Kinugawa K
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Sodium Zirconium Cyclosilicate Therapy Cessation in Patients with Systolic Heart Failure.
    Imamura T; Narang N; Kinugawa K
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Implication of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia.
    Imamura T; Narang N; Kinugawa K
    Int Heart J; 2023 Nov; 64(6):1065-1070. PubMed ID: 37967978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A; Imamura T; Narang N; Kinugawa K
    Clin Cardiol; 2021 Sep; 44(9):1272-1275. PubMed ID: 34263946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.
    Spinowitz BS; Fishbane S; Pergola PE; Roger SD; Lerma EV; Butler J; von Haehling S; Adler SH; Zhao J; Singh B; Lavin PT; McCullough PA; Kosiborod M; Packham DK;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):798-809. PubMed ID: 31110051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study.
    Dwyer JP; Agiro A; Desai P; Oluwatosin Y
    Adv Ther; 2023 Nov; 40(11):4777-4791. PubMed ID: 37606716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis.
    Zhang Y; Xu R; Wang F; Liu Y; Xu J; Zhao N; Cheng F; Long L; Jia J; Lin S
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):1057-1066. PubMed ID: 33459923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study.
    Agiro A; An A; Cook EE; Mu F; Chen J; Desai P; Oluwatosin Y; Pollack CV
    Adv Ther; 2023 Jun; 40(6):2886-2901. PubMed ID: 37140706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Rapid Recurrence of Hyperkalemia following Cessation of Sodium Zirconium Cyclosilicate.
    Imamura T; Narang N; Kinugawa K
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.
    Cases A; Gorriz JL
    Drugs Today (Barc); 2018 Oct; 54(10):601-613. PubMed ID: 30398481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait.
    Elsisi GH; Mahmoud MMI; Al-Humood K; Al-Yousef A
    J Med Econ; 2024; 27(1):253-265. PubMed ID: 38318718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Sodium Zirconium Cyclosilicate Therapy on Nutrition Status in Patients with Hyperkalemia.
    Imamura T; Fujioka H; Narang N; Kinugawa K
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA; Gales MA
    Ann Pharmacother; 2016 Jun; 50(6):502-10. PubMed ID: 27009290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of sodium zirconium cyclosilicate for up-titration of renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure: a case series.
    Williams R; James A; Ashton M; Vaughan S; Wong A
    Eur Heart J Case Rep; 2021 Aug; 5(8):ytab281. PubMed ID: 34409249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders.
    Hida Y; Imamura T; Kinugawa K
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.
    Kashihara N; Nishio T; Osonoi T; Saka Y; Imasawa T; Ohtake T; Mizuno H; Shibagaki Y; Kim H; Yajima T; Sarai N
    Clin Exp Nephrol; 2020 Dec; 24(12):1144-1153. PubMed ID: 32779057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
    Ni Z; Lu R; Xu X; Bian X; Zhou Z; Yang J; Luo Q; Chen M; Chen C; Sun X; Yu L; He Q; Jiang H; Yuan W; Li Y; Zhou R; Wang J; Zhang X; Zuo L; Meng X; Chang Z; Zhao J; Wessman P; Xiang P;
    Clin Ther; 2023 Jul; 45(7):633-642. PubMed ID: 37385905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials.
    Carvalho PEP; Veiga TMA; Lacerda H; Tofanelli MR; Gewehr DM; Nunes MCP; Simões E Silva AC
    Clin Res Cardiol; 2023 Jul; 112(7):991-1002. PubMed ID: 37140823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P; Shah S; McAlister L; Cleghorn S; King L; Shroff R
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.